NCT07634289
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07634289
Title Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma (Radio-GLO)
Acronym Radio-GLO
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Olivia Newton-John Cancer Research Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS


No variant requirements are available.